ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration
Clinical trial NCT01698736 · COMPLETED
Trial details
- NCT number
- NCT01698736
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.